MediWound (MDWD) Total Liabilities (2016 - 2026)
MediWound (MDWD) posted quarterly Total Liabilities of $42.6 million for Q4 2025, up 0.66% year-over-year from $42.3 million in Q4 2024, and down 3.71% quarter-over-quarter from $44.3 million in Q3 2025.
MediWound (MDWD) Total Liabilities (2016 - 2026) Analysis & Trends
MediWound's Total Liabilities history runs 10 years deep, the most recent figure standing at $42.6 million for Q4 2025.
- In Q4 2025, Total Liabilities rose 0.66% year-over-year to $42.6 million; the TTM figure through Dec 2025 stood at $42.6 million (up 0.66% YoY), while the FY2025 annual figure was $42.6 million, up 0.66% from the prior year.
- Total Liabilities for Q4 2025 stood at $42.6 million, down from $44.3 million in the prior quarter.
- The five-year high for Total Liabilities was $68.7 million in Q1 2023, with the low at $23.3 million in Q2 2022.
- The 5-year median for Total Liabilities is $38.4 million (2022), against an average of $37.2 million.
- The sharpest annual moves came in 2023 and 2024: Total Liabilities jumped 181.16% in 2023, then sank 42.94% in 2024.
- MediWound's Total Liabilities stood at $24.3 million in 2021, then soared by 60.74% to $39.1 million in 2022, then decreased by 10.84% to $34.9 million in 2023, then climbed by 21.45% to $42.3 million in 2024, then rose by 0.66% to $42.6 million in 2025.
- Business Quant data shows MDWD's Total Liabilities at $42.6 million in Q4 2025, $44.3 million in Q3 2025, and $46.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 86.33 Bn | 78.34 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.13 Bn | 59.95 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 60.47 Bn | 55.33 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.04 Bn | 27.73 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.48 Bn | 10.09 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.23 Bn | 26.39 Bn | - | 10.03 Bn |
| 10 | MediWound | 169.87 Mn | 138.88 Mn | 337,000.00 | 36.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.24 Mn |
| Dec 31, 2025 | 42.62 Mn |
| Sep 30, 2025 | 44.27 Mn |
| Jun 30, 2025 | 46.88 Mn |
| Mar 31, 2025 | 37.74 Mn |
| Dec 31, 2024 | 42.34 Mn |
| Sep 30, 2024 | 40.50 Mn |
| Jun 30, 2024 | 39.43 Mn |
| Mar 31, 2024 | 39.18 Mn |
| Dec 31, 2023 | 34.86 Mn |
| Sep 30, 2023 | 67.02 Mn |
| Jun 30, 2023 | 29.44 Mn |
| Mar 31, 2023 | 68.67 Mn |
| Dec 31, 2022 | 39.10 Mn |
| Sep 30, 2022 | 26.93 Mn |
| Jun 30, 2022 | 23.34 Mn |
| Mar 31, 2022 | 24.42 Mn |
| Dec 31, 2021 | 24.33 Mn |
| Sep 30, 2021 | 23.99 Mn |
| Jun 30, 2021 | 24.09 Mn |